People with mental health disorders face elevated risk of metabolic syndrome (MetS), which increases the risk of serious health problems and premature mortality. Obesity is prevalent among those hospitalized in forensic psychiatric units, and substantial weight gains during hospitalization have been reported. We examined International Diabetes Federation (IDF) criteria and proxy MetS indexes (body mass index [BMI], blood pressure, and waist circumference) in the medical records of 527 men admitted to a forensic hospital, and tested predictors of weight gain during their first year or less in hospital. IDF indexes were documented for 22% of men whereas proxy indexes were documented for 46%. Both suggested similar MetS prevalence: 16% IDF, 17% proxy. Weight gain averaged 1.72 kg per month; BMI, being a smoker, and length of stay were independent predictors. Interventions focusing on these risk factors are advisable in order to support both mental and physical health among individuals admitted to forensic psychiatric services. The proxy MetS indexes offer a rapid screening measure and a promising tool for research studies and clinical practice in the absence of blood test results.
Get full access to this article
View all access options for this article.
References
1.
AlbertiK. G.EckelR. H.GrundyS. M.ZimmetP. Z.CleemanJ. I.DonatoK. A.FruchartJ. C.JamesW. P.LoriaC. M., & SmithS. C.Jr. (2009). Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 120(16), 1640–1645. 10.1161/CIRCULATIONAHA.109.192644
2.
AlbertiK. G. M. M.ZimmetP., & ShawJ. (2006). Metabolic syndrome-a new world-wide definition. A consensus statement from the international diabetes federation. Diabetic Medicine: A Journal of the British Diabetic Association, 23(5), 469–480. 10.1111/j.1464-5491.2006.01858.x
3.
BartonB. B.SeggerF.FischerK.ObermeierM., & MusilR. (2020). Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis. Expert Opinion on Drug Safety, 19(3), 295–314. 10.1080/14740338.2020.1713091
4.
BushT.LovejoyJ. C.DepreyM., & CarpenterK. M. (2016). The effect of tobacco cessation on weight gain, obesity, and diabetes risk. Obesity (Silver Spring, Md.), 24(9), 1834–1841. 10.1002/oby.21582
5.
Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada. (2014, December). Tri-council policy statement: Ethical conduct for research involving humans. http://www.pre.ethics.gc.ca/pdf/eng/tcps2-2014/TCPS_2_FINAL_Web.pdf
6.
CarriereI.PérèsK.AncelinM. L.GourletV.BerrC.Barberger-GateauP.BouillonK.KivimakiM.RitchieK., & AkbaralyT. (2014). Metabolic syndrome and disability: Findings from the prospective three-city study. The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences, 69(1), 79–86. 10.1093/gerona/glt101
7.
ChangS.-C., & LuM.-L. (2012). Metabolic and cardiovascular adverse effects associated with treatment with antipsychotic drugs. Journal of Experimental & Clinical Medicine, 4(2), 103–107. 10.1016/j.jecm.2012.01.007
8.
CormacI.FerriterM.BenningR., & SaulC. (2005). Physical health and health risk factors in a population of long-stay psychiatric patients. Psychiatric Bulletin, 29(1), 18–20. 10.1192/pb.29.1.18
9.
DasC.MendezG.JagasiaS., & LabbateL. A. (2012). Second-generation antipsychotic use in schizophrenia and associated weight gain: A critical review and meta-analysis of behavioral and pharmacologic treatments. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists, 24(3), 225–239.
10.
De HertM.DetrauxJ.van WinkelR.YuW., & CorrellC. U. (2012). Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nature Reviews. Endocrinology, 8(2), 114–126. 10.1038/nrendo.2011.156
11.
DengC. (2013). Effects of antipsychotic medications on appetite, weight, and insulin resistance. Endocrinology and Metabolism Clinics of North America, 42(3), 545–563. 10.1016/j.ecl.2013.05.006
12.
EckelR. H.GrundyS. M., & ZimmetP. Z. (2005). The metabolic syndrome. The Lancet, 365(9468), 1415–1428. 10.1016/S0140-6736(05)66378-7
13.
EngelkeC.Lange-AsschenfeldtC.PeterS.KahlK. G.FraschK.LarsenJ. I.BickelG. G.BorkB.JacobsenB. A.Wallenstein-JensenS. O.LauberC.MogensenB.NielsenJ. A.RösslerW.TsuchiyaK. J.ToftegaardK. L.AndersenU. A.UwakweR.Munk-JørgensenP., & CordesJ. (2018). A cross-continental analysis of weight gain, psychiatric diagnoses and medication use during inpatient psychiatric treatment. The international study on physical illness in mentally ill. European Psychiatry : The Journal of the Association of European Psychiatrists, 48(1), 65–70. 10.1016/j.eurpsy.2017.11.004
14.
Every-PalmerS.HuthwaiteM. A.ElmslieJ. L.GrantE., & RomansS. E. (2018). Long-term psychiatric inpatients’ perspectives on weight gain, body satisfaction, diet and physical activity: a mixed methods study. BMC Psychiatry, 18(1), 9. 10.1186/s12888-018-1878-5
15.
HarrisG. T.RiceM. E.QuinseyV. L., & CormierC. A. (2015). Violent offenders: Appraising and managing risk (3rd ed.). American Psychological Association.
16.
HarrisK. K.ZopeyM., & FriedmanT. C. (2016). Metabolic effects of smoking cessation. Nature Reviews. Endocrinology, 12(5), 299–308. 10.1038/nrendo.2016.32
17.
HawC., & RowellA. (2011). Obesity and its complications: a survey of inpatients at a secure psychiatric hospital. The British Journal of Forensic Practice, 13(4), 270–277. 10.1108/14636641111190033
18.
HawC., & StubbsJ. (2011). What are we doing about weight management in forensic psychiatry? A survey of forensic psychiatrists. The British Journal of Forensic Practice, 13(3), 183–190. 10.1108/14636641111157823
19.
HiltonN. Z.HamE., & GreenM. (2018). The roles of antisociality and neurodevelopmental problems in criminal violence and clinical outcomes among male forensic inpatients. Criminal Justice and Behavior, 45(3), 293–315. 10.1177/0093854817745911
20.
HiltonN. Z.HamE.LangC., & HarrisG. T. (2015). Weight gain and its correlates among forensic inpatients. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 60(5), 232–238. http://journals.sagepub.com/doi/pdf/10.1177/07067437150600050510.1177/070674371506000505
JohnsonM.DayM.MoholkarR.GilluleyP., & GoyderE. (2018). Tackling obesity in mental health secure units: A mixed method synthesis of available evidence. Bjpsych Open, 4(4), 294–301. 10.1192/bjo.2018.26
23.
LevittG. A.ShinaultK.PattersonS., & OtalukaO. (2017). Weight gain in psychiatric inpatients: Are interventions making a positive impact?The Primary Care Companion for CNS Disorders, 19(04), 17m02111. 10.4088/PCC.17m02111
24.
ŁopuszańskaU.SidorK., & Marta Makara-StudzińskaM. (2017). Psychosocial determinants of metabolic disorders in individuals with psychiatric disorders. Psychiatria i Psychologia Kliniczna, 17(1), 17–22. 10.15557/PiPK.2017.0002
25.
MaT.MackinnonT., & DeanK. (2021). The prevalence of cardiometabolic disease in people with psychotic disorders in secure settings – A systematic review. Journal of Forensic Psychiatry & Psychology, 32(2), 281–307. 10.1080/14789949.2020.1859588
26.
MatA.AhernT.HoareT.McCarranP.KennedyH. G., & O’SheaD. (2015, May 16–20). The prevalence of obesity and metabolic syndrome among inpatients at a forensic psychiatric hospital in the Republic of Ireland [Paper presentation]. 17th European Congress of Endocrinology, Dublin, Ireland. [Poster session]. 10.1530/endoabs.37.EP574
27.
MitchellA. J.VancampfortD.SweersK.van WinkelR.YuW., & De HertM. (2013). Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders: A systematic review and meta-analysis. Schizophrenia Bulletin, 39(2), 306–318. 10.1093/schbul/sbr148
28.
O’NeilS., & O’DriscollL. (2015). Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obesity Reviews, 16(1), 1–12. 10.1111/obr.12229
29.
PedersenA. L. W.LindekildeC. R.AndersenK.HjorthP.GildbergF. A. (2020). Health behaviours of forensic mental health service users, in relation to smoking, alcohol consumption, dietary behaviours and physical activity—A mixed methods systematic review. Journal of Psychiatric and Mental Health Nursing, 28, 444–461. https://onlinelibrary.wiley.com/doi/abs/10.1111/jpm.12688
30.
PenninxB. W. J. H., & LangeS. M. M. (2018). Metabolic syndrome in psychiatric patients: overview, mechanisms, and implications. Dialogues in Clinical Neuroscience, 20(1), 63–73. 10.31887/dcns.2018.20.1/bpenninx
31.
PollexR. L.HanleyA. J. G.ZinmanB.HarrisS. B.KhanH. M. R., & HegeleR. A. (2006). Metabolic syndrome in aboriginal Canadians: Prevalence and genetic associations. Atherosclerosis, 184(1), 121–129. 10.1016/j.atherosclerosis.2005.03.024
32.
QuinseyV. L.ColemanG.JonesB., & AltrowsI. f. (1997). Proximal antecedents of eloping and reoffending among supervised mentally disordered offenders. Journal of Interpersonal Violence, 12(6), 794–813. 10.1177/088626097012006002
33.
RaoD. P.DaiS.LagaceC., & KrewskiD. (2014). Metabolic syndrome and chronic disease. Chronic Diseases and Injuries in Canada, 34(1), 36–45. 10.24095/hpcdp.34.1.06
34.
RiceM. E.HarrisG. T., & QuinseyV. L. (1996). Treatment for forensic patients. In SalesB. D. & ShahS. A. (Eds.), Mental health and law: Research, policy, and services (pp. 141–189). Carolina Academic Press.
35.
RingenP. A.FaerdenA.AntonsenB.FalkR. S.MamenA.RognliE. B.SolbergD. K.AndreassenO. A., & MartinsenE. W. (2018). Cardiometabolic risk factors, physical activity and psychiatric status in patients in long-term psychiatric inpatient departments. Nordic Journal of Psychiatry, 72(4), 296–302. 10.1080/08039488.2018.1449012
36.
RussellR.ChesterV.WatsonJ.NyakunuwaC.ChildL.McDermottM.DrakeS., & AlexanderR. T. (2018). The prevalence of overweight and obesity levels among forensic inpatients with learning disability. British Journal of Learning Disabilities, 46(2), 101–108. 10.1111/bld.12220
37.
SušilováL.ČeškováE.HampelD.SušilA., & ŠimůnekJ. (2017). Changes in BMI in hospitalized patients during treatment with antipsychotics, depending on gender and other factors. International Journal of Psychiatry in Clinical Practice, 21(2), 112–117. 10.1080/13651501.2017.1291818
38.
ThorndikeA. N.AchtyesE. D.CatherC.PrattS.PachasG. N.HoeppnerS. S., & EvinsA. E. (2016). Weight gain and 10-year cardiovascular risk with sustained tobacco abstinence in smokers with serious mental illness: a subgroup analysis of a randomized trial. The Journal of Clinical Psychiatry, 77(03), e320–e326. 10.4088/JCP.15m10074
39.
VancampfortD.FirthJ.SchuchF. B.RosenbaumS.MugishaJ.HallgrenM.ProbstM.WardP. B.GaughranF.De HertM.CarvalhoA. F., & StubbsB. (2017). Sedentary behavior and physical activity levels in people with schizophrenia, bipolar disorder and major depressive disorder: A global systematic review and meta-analysis. World Psychiatry, 16(3), 308–315. 10.1002/wps.20458
40.
VancampfortD.StubbsB.MitchellA. J.De HertM.WampersM.WardP. B.RosenbaumS., & CorrellC. U. (2015). Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: a systematic review and meta-analysis. World Psychiatry, 14(3), 339–347. 10.1002/wps.20252
41.
VasudevK.ThakkarP. B., & MitchesonN. (2012). Physical health of patients with severe mental illness: an intervention on medium secure forensic unit. International Journal of Health Care Quality Assurance, 25(4), 363–370. 10.1108/09526861211221527
